CAC2 Webinar–“Understanding Childhood Cancer Risk and Early Indicators” April 28, 2026 Watch On-Demand »
News Digest CAC2 Childhood Cancer Community News Digest (September 25-October 1) Assorted News from the Last Week: On September 26, 2023, the FDA approved bosutinib (Bosulif, Pfizer) for pediatric patients 1 year of age and older Read More » October 2, 2023 No Comments